（字幕）FDA ODAC - May 21, 2025 - mitomycin & TALZENNA
On the morning of May 21, 2025, the Committee will discuss new drug application (NDA) 215793, for (mitomycin) intravesical solution, submitted by UroGen Pharma, Inc. The proposed indication (use) is for the treatment of adult patients with low-grade inter
立即观看
0